This bulletin discusses the importance of appropriate patient identification prior to a procedure and highlights the challenges posed by the COVID-10 pandemic. Protocol deviations resulting from ...
This safety notice provides guidelines for identifying and treating myocarditis and pericarditis after mRNA COVID-19 vaccines. Myocarditis refers to inflammation of the heart muscle, and ...
This safety notice addresses the potential shortage of remdesivir, a nucleotide analogue prodrug that inhibits RNA polymerases. It is used to treat hospitalised patients with moderate to severe ...